1180 ALT flares in patients with HBEAG-positive chronic hepatitis B and treated with either conventional interferon alfa-2A or peginterferon alfa-2A (40KD) (PEGASYS®) are not necessary for a significant response to therapy
GRAHAM, W; COOKSLEY, E; LAI, M; PIRATVISUTH, T; WANG, Y; MAHACHAI, V; CHAO, Y; TANWANDEE, T; CHUTAPUTTI, A; CHANG, W
- 期刊名称Hepatology
- 作者GRAHAM, W; COOKSLEY, E; LAI, M; PIRATVISUTH, T; WANG, Y; MAHACHAI, V; CHAO, Y; TANWANDEE, T; CHUTAPUTTI, A; CHANG, W
- 卷第38卷
- 印刷ISSN0270-9139
- 文件大小148.68KB
- 发表时间2003
- DOI10.1016/S0270-9139(03)81218-1
- 页码724-724